RxDoctor Payments Data

Nicholas Tan, MD

Clinical Cardiac Electrophysiology · Rochester, MNNPI 1770962029

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (46.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $9,805 and has fallen 61.7% since, to $3,758 in 2025.

$21,054in general payments, 2019–2025

Across 91 payments — averaging $231.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$14K
  • Abbott$5K
  • Biotronik Inc.$1K
  • Atricure, Inc.$789
  • Boston Scientific$598
  • Philips North America LLC$47

What the payments were for

  • Grants$9,85047%
  • Travel & lodging$7,38335%
  • Food & beverage$3,24215%
  • Education$5783%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic45$13,540
Abbott27$4,589
Biotronik Inc.9$1,492
Atricure, Inc.5$789
Boston Scientific4$598
Philips North America LLC1$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,054 in reported general payments places this provider in the 65th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

See all clinical cardiac electrophysiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$115,108
Medicare patients
860
Services billed
1,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$21,647
XareltoRivaroxaban12$13,458
Amiodarone Hcl17$1,357
Metoprolol Succinate17$593
Lisinopril14$35

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →